IWM
TLX

IHT Wealth Management’s Telix Pharmaceuticals TLX Stock Holding History

IHT Wealth Management’s Portfolio TLX Stock Details TLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$372K Buy
32,295
+7,260
+29% +$73.9K 0.01% 942
2026
Q1 		$240K Sell
25,035
-250
-1% -$1.9K 0.01% 1103
2025
Q4 		$189K Sell
25,285
-923
-4% -$8.88K ﹤0.01% 1137
2025
Q3 		$251K Buy
26,208
+12,968
+98% +$159K 0.01% 1015
2025
Q2 		$213K Buy
+13,240
New +$222K 0.01% 1060

Other funds holding TLX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return
PIC
Portland Investment Counsel Burlington, Ontario, Canada $358M AUM 26.37% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
IWC
Integrated Wealth Concepts Waltham, Massachusetts $20.5B AUM 24.45% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

IHT Wealth Management's TLX Position: Q2 2026 in Review

IHT Wealth Management increased its Telix Pharmaceuticals (TLX) stake by 29% in Q2 2026, buying an estimated $73.9K and bringing the position to 32,295 shares worth $372K. The position accounts for 0.01% of the portfolio, ranked #942.

IHT Wealth Management first reported a position in TLX in Q2 2025 and has held it in 5 quarters since. 61 funds tracked by Wall St. Rank hold TLX as of Q2 2026.

  • IHT Wealth Management held 32,295 shares of Telix Pharmaceuticals worth $372K as of Q2 2026.
  • IHT Wealth Management bought 7,260 Telix Pharmaceuticals shares in Q2 2026, an estimated $73.9K.
  • Telix Pharmaceuticals made up 0.01% of IHT Wealth Management's portfolio in Q2 2026, its #942 holding.
  • IHT Wealth Management first reported a position in Telix Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
  • 61 funds tracked by Wall St. Rank held Telix Pharmaceuticals as of Q2 2026.

Based on IHT Wealth Management's 13F filing for Q2 2026, filed 14 Aug 2026.